While BECLIN-1 has not previously been implicated in diseases characterized by barrier defects, such as IBD, our findings raise the possibility of its involvement in such conditions, particularly those affecting the small bowel such as Crohn’s disease, given the severe enteritis observed following BECLIN-1 deletion. This evidence concerns the gene BECN1 and enteritis.